Company intelligence / Profile preview

Yendou

Berlin, Berlin, Germanyyendou.com ↗

Ownership: Private
Development stage: Other

Overview

Yendou has developed and commercialized an AI-powered site engagement and automation platform that streamlines site selection, feasibility assessment, and operational workflows for oncology clinical trials. The company reports rapid adoption since its March 2023 launch, with over 1,200 clinicians across 46 countries using the system. The platform reduces manual outreach time from weeks to days and centralizes site intelligence without requiring research sites to adopt new technology or portals.

Therapeutic areas: Oncology
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Pharmaceutical companiesbiotech companiescontract research organizations

Beyond the preview

Go deeper on Yendou.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yendou.

Explore the full profile